Tuberculosis vaccine trials

被引：0
|
作者：
von Reyn, CF [1 ]
机构：
[1] Dartmouth Hitchcock Med Ctr, Sect Infect Dis & Int Hlth, Lebanon, NH 03756 USA
来源：
LANCET INFECTIOUS DISEASES | 2005年 / 5卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：132 / 132
页数：1
相关论文
共 50 条
  • [11] A comparison of IFNγ detection methods used in tuberculosis vaccine trials
    Beveridge, Natalie E. R.
    Fletcher, Helen A.
    Hughes, Jane
    Pathan, Ansar A.
    Scriba, Thomas J.
    Minassian, Angela
    Sander, Clare R.
    Whelan, Kathryn T.
    Dockrell, Hazel M.
    Hill, Adrian V. S.
    Hanekom, Willem A.
    McShane, Helen
    TUBERCULOSIS, 2008, 88 (06) : 631 - 640
  • [12] Clean Blood, Religion, and Moral Triage in Tuberculosis Vaccine Trials
    Dixon, Justin
    Tameris, Michele
    MEDICAL ANTHROPOLOGY, 2018, 37 (08) : 708 - 721
  • [13] An Aspiration to Radically Shorten Phase 3 Tuberculosis Vaccine Trials
    Hill, Philip C.
    Cobelens, Frank
    Martinez, Leonardo
    Behr, Marcel A.
    Churchyard, Gavin
    Evans, Tom
    Fiore-Gartland, Andrew J.
    Garcia-Basteiro, Alberto L.
    Hanekom, Willem
    Rangaka, Molebogeng X.
    Vekemans, Johan
    White, Richard G.
    JOURNAL OF INFECTIOUS DISEASES, 2023, 228 (09): : 1150 - 1153
  • [14] Capacity building for tuberculosis vaccine clinical trials in South Africa and Senegal
    Vermaak, S.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2012, 17 : 39 - 39
  • [15] Consensus Statement on Diagnostic End Points for Infant Tuberculosis Vaccine Trials
    Hatherill, Mark
    Verver, Suzanne
    Mahomed, Hassan
    CLINICAL INFECTIOUS DISEASES, 2012, 54 (04) : 493 - 501
  • [16] Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations
    Hanekom, Willem A.
    Dockrell, Hazel M.
    Ottenhoff, Tom H. M.
    Doherty, T. Mark
    Fletcher, Helen
    McShane, Helen
    Weichold, Frank F.
    Hoft, Dan F.
    Parida, Shreemanta K.
    Fruth, Uli J.
    PLOS MEDICINE, 2008, 5 (07) : 1033 - 1036
  • [17] Designing tuberculosis vaccine efficacy trials - lessons from recent studies
    Ginsberg, Ann M.
    EXPERT REVIEW OF VACCINES, 2019, 18 (05) : 423 - 432
  • [18] Phenotypic variability in childhood TB: Implications for diagnostic endpoints in tuberculosis vaccine trials
    Mulenga, Humphrey
    Moyo, Sizulu
    Workman, Lesley
    Hawkridge, Tony
    Verver, Suzanne
    Tameris, Michele
    Geldenhuys, Hennie
    Hanekom, Willem
    Mahomed, Hassan
    Hussey, Gregory
    Hatherill, Mark
    VACCINE, 2011, 29 (26) : 4316 - 4321
  • [19] A Review of Adherence and Predictors of Adherence to the CONSORT Statement in the Reporting of Tuberculosis Vaccine Trials
    Ngah, Veranyuy D.
    Mazingisa, Akhona V.
    Zunza, Moleen
    Wiysonge, Charles S.
    VACCINES, 2020, 8 (04) : 1 - 13
  • [20] Protection by BCG Vaccine Against Tuberculosis: A Systematic Review of Randomized Controlled Trials
    Mangtani, Punam
    Abubakar, Ibrahim
    Ariti, Cono
    Beynon, Rebecca
    Pimpin, Laura
    Fine, Paul E. M.
    Rodrigues, Laura C.
    Smith, Peter G.
    Lipman, Marc
    Whiting, Penny F.
    Sterne, Jonathan A.
    CLINICAL INFECTIOUS DISEASES, 2014, 58 (04) : 470 - 480
12345